This invention relates to compounds of the formula 1 ##STR00001## wherein G, D, A, Z, Q, X, Y, R.sup.1, and R.sup.4 through R.sup.7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.